Synergistic antithrombotic effect of a combination of NO donor and plasma kallikrein inhibitor

Thrombosis Research

Volumn 116, Issue 5, 2005, Pages 403-408

  Ikarugi, Hideo ^a,b   Inoue, Ayumi ^a   Yamashita, Tsutomu ^a   Tsuda, Yuko ^a   Okada, Yoshio ^a   Ishii, Hiromitsu ^c   Yamamoto, Junichiro ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

^b UNIVERSITY OF HYOGO   (Japan)

^c Ishii Hospital   (Japan)

Author keywords

Nitric oxide; Plasma kallikrein inhibitor; Platelets; Thrombolysis; Thrombosis

Indexed keywords

NITRIC OXIDE DONOR; PKSI 527; PLASMA KALLIKREIN; S NITROSOGLUTATHIONE; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ADULT; ANTICOAGULATION; ARTICLE; BLOOD ANALYSIS; BLOOD CLOT LYSIS; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; FEMALE; HEMOSTASIS; HUMAN; IN VITRO STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THROMBOCYTE FUNCTION; VOLUNTEER;

ADULT; AGED; BLOOD PLATELETS; DRUG SYNERGISM; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; KALLIKREINS; MALE; MIDDLE AGED; NITRIC OXIDE DONORS; PHENYLALANINE; S-NITROSOGLUTATHIONE; THROMBOSIS; TRANEXAMIC ACID;

EID: 23944436944     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2005.02.002     Document Type: Article

References (23)

1. J.J. Sixma Interaction of blood platelets with the vessel wall A.L. Bloom C.D. Forbes D.P. Thomas E.G.D. Tuddenham Haemostasis and thrombosis 1994 Churchill Livingstone London 259 285
2. M.W. Radomski, R.M.J. Palmer, and S. Moncada Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium Lancet 2 1987 1057 1058
3. M. Radomski, R.M.J. Palmer, and S. Moncada An l-arginine/nitric oxide pathway present in human platelets regulates aggregation Proc Natl Acad Sci U S A 87 1990 5193 5197
4. K. Wanaka, S. Okamoto, M. Bohgaki, A. Hijikata-Okunomiya, T. Naito, and Y. Okada Effect of a highly selective plasma-kallikrein synthetic inhibitor on contact activation relating to kinin generation, coagulation and fibrinolysis Thromb Res 57 1990 889 895
5. J. Hauert, G. Nicoloso, W.D. Schleuning, F. Bachmann, and M. Schapira Plasminogen activators in dextran sulfate-activated euglobulin fractions: a molecular analysis of factor XII- and prekallikrein-dependent fibrinolysis Blood 73 1989 994 999
6. G. Motta, Z. Shariat-Madar, F. Mahdi, C.A. Sampaio, and A.H. Schmaier Assembly of high molecular weight kininogen and activation of prekallikrein on cell matrix Thromb Haemost 86 2001 840 847
7. J. Yamamoto, T. Yamashita, H. Ikarugi, T. Taka, M. Hashimoto, and H. Ishii Görög thrombosis test: a global in vitro test of platelet function and thrombolysis Blood Coagul Fibrinolysis 14 2003 31 39
8. J. Yamamoto, and I.B. Kovacs Shear-induced in-vitro haemostasis/ thrombosis tests: the benefit of using native blood Blood Coagul Fibrinolysis 14 2003 697 702
9. H. Ikarugi, T. Yamashita, R. Aoki, H. Ishii, K. Kanki, and J. Yamamoto Impaired spontaneous thrombolytic activity in elderly and in habitual smokers, as measured by a new global thrombosis test Blood Coagul Fibrinolysis 14 2003 781 784
10. J. Molloy, J.F. Martin, P.A. Baskerville, S. Fraser, and H.S. Markus S-Nitrosoglutathione reduces the rate of embolization in humans Circulation 98 1998 1372 1375
11. C.P. Ratunatunga, S.F. Edmondson, F.M. Reea, and I.B. Kovacs High-dose aspirin inhibits shear-induced platelet reaction involving thrombin generation Circulation 85 1992 1077 1082
12. S. Nakajima, T. Noguchi, T. Taka, T. Ueda, K. Kaizu, and M. Fukamizu A global platelet test of thrombosis and thrombolysis detects a prothrombotic state in some patients with non-insulin dependent diabetes and in some patients with stroke Platelets 11 2000 459 466
13. M.T. Santos, J. Valles, A.J. Marcus, L.B. Safier, M.J. Broekman, and N. Islam Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment J Clin Invest 87 1991 571 580
14. 4 cooperative synthesis Thromb Haemost 72 1994 450 456
15. K.S. Sakariassen, M. Ottenhof-Rovers, and J.J. Sixma Factor VIII-von Willebrand factor requires calcium for facilitation of platelet adherence Blood 63 1984 996 1003
16. T. Yamashita, J. Yamamoto, Y. Sasaki, and A. Matsuoka The antithrombotic effect of low molecular weight synthetic thrombin inhibitors, argatroban and PPACK, on He-Ne laser-induced thrombosis in rat mesenteric microvessels Thromb Res 69 1993 93 100
17. D.W. Stepp, Y. Nishikawa, and W.M. Chilian Regulation of shear stress in the canine coronary microcirculation Circulation 100 1999 1555 1561
18. J. Strony, A. Beaudoin, D. Brands, and B. Adelman Analysis of shear stress and hemodynamic factors in a model of coronary artery stenosis and thrombosis Am J Physiol 265 1993 H1787 H1796
19. A.R. Folsom Hemostatic risk factors for atherothrombotic disease: an epidemiologic view Thromb Haemost 86 2001 366 373
20. M.W. Radomski, D.D. Rees, A. Dutra, and S. Moncada S-Nitrosogultachione inhibits platelet activation in vitro and in vivo Br J Pharmacol 107 1992 745 749
21. P. Krement, P. Liao, and L. Bajzar A novel approach to arterial thrombolysis Blood 94 1999 2735 2743
22. M. Nagashima, M. Werner, M. Wang, L. Zhao, D.R. Light, and R. Pagila An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model Thromb Res 98 2000 333 342
23. M.R. Davis, D.P. Ortegon, J.D. Kerby, L.J. Ignarro, and V.S. Kashyap Endothelial dysfunction after arterial thrombosis is ameliorated by l-arginine in combination with thrombolysis J Vasc Interv Radiol 14 2003 233 239